We offer expert abuse and dependence evaluations to support US, UK, European and Japanese drug registrations. Services including 8-factor analyses, briefing documents to support non-clinical abuse testing programs and abuse potential waiver submissions
DevelRx’ consultants have a broad background in neuroscience and have worked for many years on the development of new methods to assess the efficacy and safety of new drugs to treat attention-deficit hyperactivity disorder
Our consultants supported the development of the first drug marketed for the management of moderate to severe binge-eating disorder in adults
Our consultants have over 30 years of experience of research and development of CNS drugs used in psychiatry and neurology
We provide expert advice on pathways for successful drug development of new drugs to treat obesity and metabolic diseases
Our extensive knowledge of CNS pharmacology and expertise in drug abuse evaluation means that we are ideally placed to support companies developing novel therapeutics based on psychedelics and cannabinoids